A Digital Solution To Cancer Prognosis cleared by the UK’s Medicines & Healthcare products Regulatory Agency (MHRA), Digistain is a patented risk profiling test for hormone receptor-positive breast cancer patients.
https://www.youtube.com/watch?v=vjfM4onfCX0